Skip to main content

TomEnterprise AB's Form 4 filing

DiaMedica Therapeutics Inc. (DMAC) · filed Jun 27, 2023

Accession no.
0001104659-23-075250
Filed
Jun 27, 2023, 4:11 PM ET
Trade date
Jun 23, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $5.00M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
TomEnterprise ABCIK 000188743510% Owner
Von Koch ThomasCIK 000193891510% Owner
TomEnterprise Private ABCIK 000195678210% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 23, 2023Common SharesPPurchaseAcquired+1,470,588$3.40+$4,999,999.24,326,435Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)